The Warburg effect — the conversion of glucose to lactate even in the presence of oxygen — is not just a feature of cancer cells. It is also characteristic of rapidly proliferating cells like CHO cells used in biopharmaceutical production. I have written extensively about how niacinamide (vitamin B3, also called nicotinamide) can shift metabolism away from glycolysis and toward oxidative phosphorylation (OXPHOS) by increasing NAD+ levels. Mainstream oncology, however, continues to push “cancer starvation” therapies that deprive tumors of glucose — an approach that, as I have shown repeatedly, backfires spectacularly by forcing cancer cells into a dormant, therapy-resistant state. The study below, using CHO cells, provides direct experimental evidence that niacinamide reverses the Warburg effect and forces cells to consume lactate instead of secreting it — exactly the metabolic shift that cancer cells need to become vulnerable, not resistant.
As the study below demonstrates, niacinamide (NAM) supplementation in fed-batch CHO cell cultures reduced peak lactate by 40% and induced the lactate switch 3 days earlier than control conditions. The mechanism is clear: NAM is converted to NAD+ via the salvage pathway (NAMPT → NMN → NAD+), raising intracellular NAD+ levels. This shifts the NAD+/NADH ratio to favor lactate consumption (lactate → pyruvate via LDH, generating NADH) rather than lactate production. Transcriptomic analysis confirmed upregulation of mitochondrial ETC genes (Nd1, Nd2, Nd3, Nd4, Nd4l, Nd5, Cytb, Apt6) and downregulation of glycolytic genes — a complete reversal of the Warburg effect.
The human-equivalent dose (HED) for niacinamide: The study used nominal bioreactor concentrations of 2–5 mM niacinamide. Based on the benchmark that a 3g bolus dose of niacinamide produces approximately 1 mmol/L serum concentration in humans, achieving the 2–5 mM range would require 6–15 grams. However, the study notes that growth attenuation occurred at higher concentrations (5 mM), suggesting the optimal human dose for Warburg reversal without excessive growth suppression is likely in the 3–6 gram range — ideally divided into multiple doses throughout the day to maintain elevated NAD+ without peaking too high. This is consistent with what I have said for years: niacinamide at gram-level doses is a safe, inexpensive metabolic therapy that shifts cellular energy production toward oxidative metabolism.
The implications for cancer are profound. If niacinamide can force CHO cells (which share core metabolic machinery with human cells) to stop secreting lactate and start consuming it, then the same logic applies to cancer cells. Instead of starving them of glucose (which triggers dormancy and resistance), we should be reversing their Warburg metabolism with niacinamide, making them reliant on OXPHOS — and thus reverting them back to their normal metabolic state. The quotes below support that conclusion, as does the previous work I have posted on the forum and on my blog.
https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.70224
“…A key challenge still faced by the biopharmaceutical industry is the accumulation of lactate in cell culture. Lactate accumulation is a result of aerobic glycolysis, also known as the Warburg effect, which is the conversion of glucose to lactate despite the presence of oxygen. The Warburg effect is characteristic of CHO cells.”
“…Figure 1a demonstrates that NAM feed supplementation significantly reduced the average peak lactate concentration, lowering it from an average of 4.0 g/L in the control triplicates to 2.4 g/L in the 2 mM and 5 mM NAM-fed cultures (p = 1.5×10-4), a 40% decrease in peak lactate concentration. As well as decreasing peak lactate, NAM feeding induced a shift to lactate consumption, with the lactate shift occurring on day 5 for both the 2 mM and 5 mM fed cultures, compared to day 8 in the control cultures.”
“…This early switch to lactate consumption is attributed to the conversion of NAM to NAD+ via the salvage pathway, mediated by NAMPT through NMN, leading to increased NAD+ concentrations. The resulting elevated NAD+/NADH ratio strongly favours NAD+ consumption, converting lactate to pyruvate via LDH while generating NADH.”
“…Transcriptomic analysis reveals a shift from glycolytic to oxidative metabolism… DGE analysis between control and NAM-fed revealed 113 upregulated genes and 186 downregulated genes… A key observation is the upregulation of multiple genes in the mitochondrial ETC, particularly Nd1, Nd2, Nd3, Nd4, Nd4l, Nd5, Cytb, and Apt6, which encode subunits of mitochondrial Complexes I, III, and V. This strongly suggests an increase in OXPHOS activity in NAM-fed cultures.”
“…Functional gene enrichment analysis using GSEA… of the four altered pathways, three positively enriched pathways were related to oxidative phosphorylation and mitochondrial ETC activity, while the negatively enriched pathway was linked to PI3K/AKT/mTOR signalling. These findings reinforce the metabolic shift towards OXPHOS and the suppression of growth-associated signalling pathways in NAM-fed cultures.”
“…In this study, NAD+ precursor NAM was supplemented in a fed-batch CHO cell culture. NAM supplementation reduces peak lactate by 40% and reverses the Warburg effect to induce the lactate shift 3 days earlier than control conditions. Transcriptomic data reveal NAM promotes a shift from glycolytic to oxidative metabolism, with an upregulation of key mitochondrial ETC genes.”
Via: https://haidut.me/?p=3029
